GENE ONLINE|News &
Opinion
Blog

Anemia
Trials & Approvals Anemia
GSK’s Jesduvroq Wins FDA Approval for First Oral Drug for Anemia In Chronic Kidney Disease
2023-02-02
Trials & Approvals Bristol Myers Squibb
Bristol Myers Squibb Releases Promising Preliminary Anemia Clinical Trial Results
2022-10-31
Licensing Anemia
Akebia Therapeutics Gains $55M Following Deal Termination by Otsuka Pharmaceutical
2022-07-04
M&A Oncology
GSK to Acquire Biopharmaceutical Company Sierra Oncology for $1.9B
2022-04-17
Trials & Approvals Anemia
European Commission Approves Global Blood Therapeutics’ Oxbryta for Sickle Cell Disease
2022-02-17
Trials & Approvals Sanofi
Sanofi’ Enjaymo Wins FDA Approval for Rare Autoimmune Anemia
2022-02-07
Technology CRISPR
Vertex to Reap Majority Profits from Gene Editing Deal with CRISPR Therapeutics
2021-04-21
Trials & Approvals Sickle Cell Disease
Bluebird Bio Temporarily Suspends Sickle Cell Trials Following Cancer Diagnosis in Two Patients
2021-02-18
Trials & Approvals Sickle Cell Disease
Imara’s Sickle Cell Disease Therapy Impresses in Phase 2 Trial
2021-01-09
Ranking & Reports COVID-19
GeneOnline’s Top 10 Headlines of the Year
2020-12-30
Technology
CRISPR Gene-Edited Therapy CTX001 Raises Hopes for Sickle Cell Disease and β-Thalassemia Cures
2020-12-07
Trials & Approvals CRISPR
CRISPR, Vertex’s Gene Editing Based Therapy, CTX001 Prospers in Hemoglobinopathy Trials
2020-06-18
Trials & Approvals Beta-thalassemia
Celgene, Acceleron’s novel anemia drug gets FDA green light for rare blood disorder
2019-11-11
LATEST
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
InMed Pharmaceuticals’ Positive Market Response to Cannabinoid Analog INM-901 for Alzheimer’s Treatment
2024-09-04
Alnylam Pharma Shares Dip Despite Positive Phase 3 HELIOS-B Heart Disease Results
2024-09-04
READ MORE
EVENT
2024-09-11
2024 Bio Asia Pacific
Bangkok, Thailand
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top